The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms

R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle… - Leukemia, 2022 - nature.com
We herein present an overview of the upcoming 5th edition of the World Health Organization
Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid …

Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021

Q Wu, W Qian, X Sun, S Jiang - Journal of hematology & oncology, 2022 - Springer
Abstract The United States Food and Drug Administration (US FDA) has always been a
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …

The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee

E Campo, ES Jaffe, JR Cook… - Blood, The Journal …, 2022 - ashpublications.org
Since the publication of the Revised European-American Classification of Lymphoid
Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have …

Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop

A Di Napoli, L Soma, L Quintanilla-Martinez… - Virchows Archiv, 2023 - Springer
Abstract The 2022 European Association for Haematopathology/Society for
Hematopathology lymphoma workshop session on cavity-based lymphomas included sixty …

Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities

JY Song, S Dirnhofer, MA Piris, L Quintanilla-Martínez… - Virchows Archiv, 2023 - Springer
Diffuse large B-cell lymphoma (DLBCL) is an aggressive and heterogenous group of
diseases and the most common subtype of non-Hodgkin lymphoma. In the past decade …

Microbiota in cancer: molecular mechanisms and therapeutic interventions

Z Chen, D Guan, Z Wang, X Li, S Dong, J Huang… - MedComm, 2023 - Wiley Online Library
The diverse bacterial populations within the symbiotic microbiota play a pivotal role in both
health and disease. Microbiota modulates critical aspects of tumor biology including cell …

Co-infection of the Epstein–Barr virus and the Kaposi sarcoma-associated herpesvirus

M Böni, L Rieble, C Münz - Viruses, 2022 - mdpi.com
The two human tumor viruses, Epstein–Barr virus (EBV) and Kaposi sarcoma-associated
herpesvirus (KSHV), have been mostly studied in isolation. Recent studies suggest that co …

Herpes Simplex virus, human papillomavirus, and cervical cancer: overview, relationship, and treatment implications

DG Sausen, O Shechter, ES Gallo, H Dahari… - Cancers, 2023 - mdpi.com
Simple Summary Many different viruses are known to cause cancer. It is well known that
human papillomavirus is a causative agent of cervical carcinoma. What is more controversial …

Clinical management of Kaposi sarcoma herpesvirus-associated diseases: An update on disease manifestations and treatment strategies

R Patel, K Lurain, R Yarchoan… - Expert Review of Anti …, 2023 - Taylor & Francis
Introduction Kaposi sarcoma herpes virus (KSHV) is associated with several diseases
including Kaposi sarcoma, a form of multicentric Castleman's disease, primary effusion …

Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B …

L Quintanilla-Martinez, C Laurent, L Soma, SB Ng… - Virchows Archiv, 2023 - Springer
Emerging entities and molecular subgroups in large B-cell lymphomas (LBCLs) were
discussed during the 2022 European Association for Haematopathology/Society for …